SMAD3 and neoplasm: Therefore, to test events further downstream in the TGFβ pathway, we observed that augmentation of phospho-SMAD3, as well as their nuclear translocation, was enhanced in tumor-CD8+ Treg in comparison with control CD8+ T cells (Fig. 4C and D).